NCT00236002View on ClinicalTrials.gov

Cancer and Osteoporosis Research With Alendronate and Lupron (C.O.R.A.L )

PHASE3TerminatedINTERVENTIONAL
Enrollment

182

Participants

Timeline

Start Date

July 31, 2005

Primary Completion Date

November 30, 2007

Study Completion Date

August 31, 2009

Conditions
Osteoporosis
Interventions
DRUG

Alendronate

Alendronate 70mgm once a week for one year

Sponsors

Collaborators (1)

Abbott
All Listed Sponsors
collaborator

Abbott

INDUSTRY

collaborator

Merck Frosst Canada Ltd.

INDUSTRY

lead

Canadian Urology Research Consortium

OTHER